Clinical bottom line
Chronic cough, defined as a cough lasting more than eight weeks, is a common and often challenging condition encountered in otolaryngology. Recent advancements in understanding the pathophysiology and management of chronic cough have led to more targeted therapeutic approaches. This evidence digest summarizes the latest findings and their potential implications for clinical practice.
What the evidence shows
Recent studies have highlighted the role of neurogenic inflammation and heightened cough reflex sensitivity in chronic cough. A systematic review by Morice et al. (2020) emphasizes the importance of identifying underlying causes such as gastroesophageal reflux disease (GERD), upper airway cough syndrome (UACS), and asthma, which are prevalent in chronic cough patients [1].
Emerging therapies targeting the neural pathways involved in cough reflex have shown promise. A randomized controlled trial by Smith et al. (2021) evaluated the efficacy of a novel P2X3 receptor antagonist, which significantly reduced cough frequency and improved quality of life in patients with refractory chronic cough [2].
Additionally, a meta-analysis by Chung et al. (2022) supports the use of gabapentin, an antineuralgic agent, in reducing cough severity and frequency, particularly in patients with unexplained chronic cough [3].
Caveats and uncertainty
While these advancements offer hope, several uncertainties remain. The heterogeneity of chronic cough etiology necessitates a personalized approach, and not all patients respond uniformly to treatments. The long-term safety and efficacy of novel agents like P2X3 receptor antagonists require further investigation, as highlighted by the limited duration of current trials [2].
Moreover, the role of lifestyle modifications and non-pharmacological interventions, such as speech therapy, remains underexplored in the context of chronic cough management. The variability in diagnostic criteria and treatment protocols across studies also complicates the synthesis of evidence into practice guidelines.
How this may change practice
The integration of novel pharmacological treatments targeting neural pathways could revolutionize the management of chronic cough, particularly for patients with refractory symptoms. Clinicians should consider a comprehensive evaluation to identify and treat underlying causes while remaining open to emerging therapies that address cough reflex hypersensitivity.
Incorporating these advancements into practice may involve multidisciplinary collaboration, including pulmonologists and gastroenterologists, to optimize patient outcomes. As more evidence becomes available, updates to clinical practice guidelines will likely reflect these new therapeutic options, offering clinicians additional tools to manage this challenging condition effectively.